Journals / Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2016 / Cilt: 27 - Sayı: 2

The Effect of Prophylactic Topical Brimonidine on Intraocular Pressure After Nd: YAG Laser Posterior Capsulotomy

Profilaktik Topikal Brimonidine Kullanılanımının Nd: YAG Laser Arka Kapsülotomi Sonrası Göz İçi Basınç Değişimlerine Etkisi

Pages
107–110
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, there was no significant IOP increase as result of fewer shots and low energy laser treatment

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: The aim of this study was to evaluate the effect of topical brimonidine on intraocular pressure (IOP) after Neodymium: yttrium aluminum garnet laser posterior capsulotomy.Methods: Forty patients (40 eyes) who underwent posterior capsulotomy were included in the study.
📊
Key Findings & Data:Topical brimonidine was applied 1 hour prior to and right after laser procedure in Group A.
💡
Conclusion & Impact:In addition, there was no significant IOP increase as result of fewer shots and low energy laser treatment
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: The aim of this study was to evaluate the effect of topical brimonidine on intraocular pressure (IOP) after Neodymium: yttrium aluminum garnet laser posterior capsulotomy.Methods: Forty patients (40 eyes) who underwent posterior capsulotomy were included in the study. Patients were divided into Groups A and B. Topical brimonidine was applied 1 hour prior to and right after laser procedure in Group A. Group B was assessed as control group. Intraocular pressures of the patients were measured using aplanation tonometry (Goldmann) before, 1 hour, 1 day and 1 week after laser procedures.Results: Mean IOP at baseline was 14.7±3 mmHg in Group A and 14.6±3.9 mmHg in Group B. In Group A, IOP decreased to 12.7±3.3 mmHg after 1 hour, 13.7±2.3 mmHg after 1 day, and 14.2±2.3 mmHg after 1 week. The values were measured respectively as 15.1±2.9 mmHg, 14.9±2.1 mmHg, and 14.5±2 mmHg in Group B. IOP had decreased significantly at 1 hour and at 1 day after laser treatment when compared with baseline in Group A; no significant difference was found after 1 week. No statistically significant difference was found during follow-up period compared to baseline in Group B.Conclusion: Use of brimonidine was demonstrated to prevent rise in IOP. In addition, there was no significant IOP increase as result of fewer shots and low energy laser treatment

Özet

Amaç: Neodymium: yttrium aluminum garnet (Nd: YAG) laser arka kapsülotomi yapılan hastalarda profilaktik topikal brimonidine kulanımının göz içi basıncı (GİB) üzerine etkisini değerlendirmek.Gereç ve Yöntem: Arka kapsülotomi yapılan 40 hastanın 40 gözü çalışmaya dahil edildi. Hastalar A ve B olarak 2 gruba ayrıldı. A grubundaki 20 hastaya laser öncesi 1. saat ve laserden hemen sonra topikal brimonidine kullanılırken, B grubundaki 20 hasta kontrol grubu olarak belirlendi. Hastaların laser öncesi, laser sonrası 1. saat, 1. gün ve 1. hafta GİB değerleri aplanasyon tonometri (Goldmann) ile ölçüldü.Bulgular: Laser tedavisi öncesi ortalama GİB değeri A grubunda 14.7±3 mmHg, B grubunda 14.6±3.9 mmHg idi. Laser sonrası GİB 1. saat, 1. gün ve 1. hafta değeri sırasıyla A grubunda 12.7±3.3 mmHg, 13.7±2.3 mmHg, 14.2±2.3 mmHg iken B grubunda 15.1±2.9 mmHg, 14.9±2.1 mmHg, 14.5±2 mmHg olarak ölçüldü. Laser öncesine göre laser sonrası 1. saat ve 1. günde A grubunda anlamlı bir azalma görülürken, B grubunda laser sonrası anlamlı bir fark bulunmadı. Her iki grupta da laser sonrası 1. hafta değerlerinde laser öncesine göre istatistiksel olarak anlamlı bir fark bulunmadı.Sonuç: Çalışmamızda profilaktik brimodine kullanımının GİB artışını önlediği ancak düşük enerji ve düşük atım sayısı kullanılan ve profilksi yapılmayan GİB normal hastalarda GİB'de anlamlı bir artış olmadığı görüldü

🔖

Cite This Article

BULUT, M. N., AYYILDIZ, T., ORAL, A. Y., AKMAZ, B., ÇALLI, Ü., ÖZERTÜRK, Y. (2022). The Effect of Prophylactic Topical Brimonidine on Intraocular Pressure After Nd: YAG Laser Posterior Capsulotomy. Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 27 - Sayı: 2, 107–110. https://ajindex.com/articles/571264

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Apple DJ, Solomon KD, Tetz MR, Assia EI, Holland EY, Legler UF, et al. Posterior capsule opacification. Surv Ophthalmol 1992;37:73–116
  2. Apple DJ, Peng Q, Visessook N, Werner L, Pandey SK, Escobar-Gomez M, et al. Surgical prevention of posterior capsule opacification. Part 1: Progress in eliminating this complication of cataract surgery. J Cataract Refract Surg 2000;26:180–7
  3. Peng Q, Visessook N, Apple DJ, Pandey SK, Werner L, Escobar-Gomez M, et al. Surgical prevention of posterior capsule opacification. Part 3: Intraocular lens optic barrier effect as a second line of defense. J Cataract Refract Surg 2000;26:198–213
  4. Apple DJ. Influence of intraocular lens material and design on postoperative intracapsular cellular reactivity. Trans Am Ophthalmol Soc 2000;98:257–83
  5. Holweger RR, Marefat B. Intraocular pressure change after neodymium:YAG capsulotomy. J Cataract Refract Surg 1997;23:115–21
  6. Polak M, Zarnowski T, Zagórski Z. Results of Nd:YAG laser capsulotomy in posterior capsule opacification. Ann Univ Mariae Curie Sklodowska Med 2002;57:357–63
  7. Steinert RF, Puliafito CA, Kumar SR, Dudak SD, Patel S. Cystoid macular edema, retinal detachment, and glaucoma after Nd:YAG laser posterior capsulotomy. Am J Ophthalmol 1991;112:373–80
  8. Billotte C, Berdeaux G. Adverse clinical consequences of neodymium:YAG laser treatment of posterior capsule opacification. J Cataract Refract Surg 2004;30:2064–71
  9. Lin JC, Katz LJ, Spaeth GL, Klancnik JM Jr. Intraocular pressure control after Nd:YAG laser posterior capsulotomy in eyes with glaucoma. Br J Ophthalmol 2008;92:337–9
  10. Cai JP, Cheng JW, Wei RL, Ma XY, Jiang F, Zhu H, et al. Prophylactic use of timolol maleate to prevent intraocular pressure elevation after Nd-YAG laser posterior capsulotomy. Int Ophthalmol 2008;28:19–22
  11. Gartaganis SP1, Mela EK, Katsimpris JM, Petropoulos JK, Karamanos NK, Koliopoulos JX. Use of topical brimonidine to prevent intraocular pressure elevations following Nd:YAG-laser posterior capsulotomy. Ophthalmic Surg Lasers 1999;30:647–52
  12. Pollack IP, Brown RH, Crandall AS, Robin AL, Stewart RH, White GL. Prevention of the rise in intraocular pressure following neodymium-YAG posterior capsulotomy using topical 1% apraclonidine. Arch Ophthalmol 1988;106:754–7
  13. Öner V, Alakuş MF, Taş M, Türkyılmaz K, Işcan Y. Fixed combination brimonidine-timolol versus brimonidine for treatment of intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy. J